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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Iron deficiency anemia (IDA) is the most common type of anemia. This
study evaluated whether IDA patients had specific oral manifestations and a particular blood
profile compared to normal controls.
Methods: The oral manifestations and mean red blood cell (RBC) count, corpuscular cell vol-
ume, RBC distribution width, Mentzer index, and Green and King index as well as blood concen-
trations of hemoglobin, iron, total iron binding capacity, vitamin B12, folic acid, and
homocysteine in 75 IDA patients and in 150 age- and sex-matched healthy controls were
measured and compared.
Results: IDA patients had significantly higher frequencies of all oral manifestations than
healthy controls (p < 0.001 for all), in which burning sensation of oral mucosa (76.0%), lingual
varicosity (56.0%), dry mouth (49.3%), oral lichen planus (33.3%), and atrophic glossitis (26.7%)
were the five leading oral manifestations for IDA patients. Moreover, IDA patients had signifi-
cantly lower mean hemoglobin level, RBC count, corpuscular cell volume, Mentzer index, iron
level, and vitamin B12 level (p < 0.001 for all except p Z 0.003 for vitamin B12) as well as
significantly higher mean RBC distribution width, Green and King index and total iron binding
capacity level (p < 0.001 for all) than healthy controls. However, no significant difference inave no conflicts of interest relevant to this article.
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84 Y.-C. Wu et al.the mean blood folic acid or homocysteine level was found between 75 IDA patients and 150
healthy controls.
Conclusion: IDA patients have specific oral manifestations and a particular blood profile
compared to normal controls.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Iron deficiency anemia (IDA) is the most common type of
anemia, with women being more frequently affected than
men. It is estimated that 20% of women of childbearing age
in the USA are iron-deficient due to the chronic blood loss
associated with excessive menstrual flow. Moreover, 2% of
adult men are iron-deficient because of chronic blood loss
related to gastrointestinal diseases, such as peptic ulcer,
diverticulosis, or malignancies.1 In addition to chronic
blood loss, an increased demand for red blood cell (RBC)
production during childhood growth spurts and during
pregnancy, a decreased intake of iron during infancy and
old-age stage, and a reduced absorption of iron in patients
with total gastrectomy or celiac sprue are also possible
causes of IDA.1
Patients with IDA may have characteristic systemic
symptoms such as fatigue, weakness, lightheadedness,
shortness of breath, and palpitations. Oral symptoms and
signs may include atrophic glossitis (AG), generalized oral
mucosal atrophy, and tenderness or burning sensation of
oral mucosa.1 However, it is still not known whether IDA
patients may have specific oral manifestations and what
percentages of IDA patients may have these specific oral
manifestations. In this study, 75 IDA patients were
collected from the oral mucosal disease clinic of National
Taiwan University Hospital (NTUH). Their oral manifesta-
tions [including burning sensation and numbness of oral
mucosa, dry mouth, dysfunction of taste, lingual varicosity,
AG, recurrent aphthous ulcerations (RAU), and oral lichen
planus (OLP)], complete blood count, and blood chemistry
[including blood levels of hemoglobin (Hb), iron, vitamin
B12, folic acid, and homocysteine] were inquired, exam-
ined, and recorded. These data were compared with cor-
responding data in 150 age- and sex-matched healthy
control individuals without oral mucosal and systemic dis-
eases to assess whether IDA patients had higher frequencies
of specific oral manifestations and a particular blood profile
compared to healthy controls.
Materials and methods
Participants
The study group consisted of 75 IDA patients (11 men and 64
women, age range, 20e88 years, mean 51.7  14.1 years).
For each patient, two age- ( 2 years of each patient’s age)
and sex-matched healthy controls were selected. Thus, the
normal control group consisted of 150 healthy individuals
(22 men and 128 women, age range, 21e89 years, mean
52.4  13.8 years). All the patients and controls were seenconsecutively, diagnosed, treated, and selected in the oral
mucosal disease clinic of NTUH from July 2007 to June
2013. Patients were diagnosed as having IDA when men had
hemoglobin < 13 g/dL, women had hemoglobin < 12 g/dL,
and all of them had serum iron level < 60 mg/dL according
to the World Health Organization criteria.2,3 Burning mouth
syndrome (BMS) was diagnosed when patients had a burning
sensation of the oral mucosa in the absence of clinically
apparent mucosal alterations.4,5 Patients were diagnosed
as having partial or complete AG when their dorsal tongues
showed partial or complete absence or flattening of filiform
papillae, respectively.5,6 RAU was diagnosed when patients
had at least one episode of oral ulcerations per month
during the preceding years.7 OLP was diagnosed according
to the following criteria: (1) a typical clinical presentation
of radiating grayish-white Wickham striae or papules
(nonerosive OLP) combined with erosion or ulceration on
the bilateral buccal or vestibular mucosa (erosive OLP); and
(2) biopsy specimens characteristic of OLP, that is, hyper-
keratosis or parakeratosis, a slightly acanthotic epithelium
with liquefaction degeneration of the basal epithelial cells,
a pronounced band-like lymphocytic infiltrate in the lamina
propria, and the absence of epithelial dysplasia.8e10 How-
ever, all IDA patients with areca quid chewing habit,
autoimmune diseases (such as systemic lupus erythemato-
sus, rheumatoid arthritis, Sjogren’s syndrome, pemphigus
vulgaris, and cicatricial pemphigoid), inflammatory dis-
eases, malignancy, or recent surgery were excluded. In
addition, all IDA patients with serum creatinine concen-
trations indicative of renal dysfunction (i.e., men,
>131 mM; women, >115 mM), and who reported a history of
stroke, heavy alcohol use, or diseases of the liver, kidney,
or coronary arteries were also excluded.11 Healthy controls
had either dental caries or mild periodontal diseases but
did not have any oral mucosal or systemic diseases. None of
our IDA patients had taken any prescription medication for
BMS, AG, RAU or OLP at least 3 months prior to entering the
study.
According to the aforementioned diagnostic criteria, the
75 IDA patients included 22 with OLP only, 19 with RAU only,
17 with AG only, 14 with BMS only, and three with both OLP
and AG. For all IDA patients and healthy controls, oral
manifestations including burning sensation and numbness
of oral mucosa, dry mouth, dysfunction of taste, lingual
varicosity, AG, RAU, and OLP were inquired, examined, and
recorded. Blood samples were drawn from all patients and
healthy controls for measurement of complete blood count,
blood iron, vitamin B12, folic acid, and homocysteine
concentrations. All patients and healthy controls signed
informed consents prior to entering the study. This study
was reviewed and approved by the Institutional Review
Board at the NTUH.
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The complete blood count and blood iron, vitamin B12, folic
acid, and homocysteine concentrations were determined
by the routine tests performed in the Department of Lab-
oratory Medicine of NTUH.
Statistical analysis
Comparisons of the mean RBC count, corpuscular cell vol-
ume (MCV), RBC distribution width (RDW), Mentzer index,
and Green and King (G&K) index as well as mean blood
levels of Hb, iron, total iron binding capacity (TIBC),
vitamin B12, folic acid, and homocysteine between 75 IDA
patients and 150 age- and sex-matched healthy controls
were performed by Student t test. The differences in fre-
quency of Hb, vitamin B12 or folic acid deficiency or of
abnormally high blood homocysteine level between 75 IDA
patients and 150 age- and sex-matched healthy controls
were compared by Chi-square test. In addition, the differ-
ences in frequency of each oral manifestation between 75
IDA patients and 150 age- and sex- matched healthy con-
trols were also compared by Chi-square test. The result was
considered to be significant if p < 0.05.
Results
The mean RBC count, MCV, RDW, Mentzer index, and G&K
index as well as blood concentrations of Hb, iron, TIBC,
vitamin B12, folic acid, and homocysteine in 75 IDA patients
and in 150 age- and sex-matched healthy controls are
shown in Table 1. Because men usually had higher bloodTable 1 Mean red blood cell (RBC) count, mean corpuscular cel
and Green and King (G&K) index as well as mean blood concent
(TIBC), vitamin B12, folic acid, and homocysteine in 75 patients
matched healthy controls.
Patients with IDA (n Z 75)
Mean  SD Range
Hb (g/dL)
Men 10.6  1.9 (n Z 11) 6.9e12.7
Women 10.5  1.3 (n Z 64) 7.1e11.9
RBC ( 1012/L) 4.3  0.4 3.1e5.2
MCV (fl) 78.3  8.5 57.9e103.8
RDW (%) 15.8  2.4 12.1e23.5
Mentzer index 18.4  3.6 12.2e33.1
G&K index 92.1  16.8 57.2e145.2
Iron (mg/dL)
Men 30.4  14.3 (n Z 11) 10.0e55.0
Women 31.2  13.4 (n Z 64) 10.0e58.0
TIBC (mg/dL) 398.3  67.6 207.0e527.0
Vitamin B12 (pg/mL) 544.7  278.9 150.0e1000.0
Folic acid (ng/mL) 13.0  6.3 2.8e24.0
Homocysteine (mM) 8.7  5.0 3.6e39.9
*Comparisons of the mean RBC count, MCV, RDW, Mentzer index, an
vitamin B12, folic acid, and homocysteine between 75 IDA patients a
Mentzer index Z MCV/ RBC; G&K index Z MCV2  RDW/ (Hb  100).levels of Hb and iron than women, these two mean levels
were calculated separately for men and women. IDA pa-
tients had significantly lower mean Hb level (for both men
and women), RBC count, MCV, Mentzer index, iron level (for
both men and women), and vitamin B12 level (p < 0.001 for
all except pZ 0.003 for vitamin B12) as well as significantly
higher mean RDW, G&K index, and TIBC level (p < 0.001 for
all) than healthy controls (Table 1). However, no significant
difference in the mean blood folic acid or homocysteine
level was discovered between 75 IDA patients and 150
healthy controls (Table 1). Previous studies suggested
Mentzer index < 13 and G&K index < 65 as the criteria in
differentiating b-thalassemia trait (b-TT) from pure
IDA,12e18 i.e., b-TT patients usually have Mentzer
index < 13 and G&K index < 65, whereas IDA patient often
have Mentzer index > 13 and G&K index > 65. This study
also found that all our 150 healthy controls and 75 IDA
patients except one IDA patient had Mentzer index > 13 and
G&K index > 65.
According to the World Health Organization criteria,
men with hemoglobin < 13 g/dL and women with
hemoglobin < 12 g/dL were defined as having hemoglobin
deficiency or anemia.2 Furthermore, patients with serum
iron level < 60 mg/dL,3 serum vitamin B12 level < 200 pg/
mL (148 pmol/L),11 or folic acid level < 4 ng/mL (10 nM)19
were defined as having iron, vitamin B12, or folic acid
deficiency, respectively. In addition, patients with the
blood homocysteine level > 12.1 mmol/L (which was the
mean blood homocysteine level of healthy controls plus two
standard deviations) were defined as having abnormally
high homocysteine level. By the above-mentioned defini-
tions, 75 (100%), six (8.0%), and two (2.7%) of 75 IDA pa-
tients had Hb, vitamin B12, and folic acid deficiencies,l volume (MCV), RBC distribution width (RDW), Mentzer index,
rations of hemoglobin (Hb), iron, total iron binding capacity
with iron deficiency anemia (IDA) and in 150 age- and sex-
Healthy controls (n Z 150) p (Student
t test)Mean  SD Range
15.1  0.7 (n Z 22) 13.8e16.3 <0.001*
13.6  0.8 (n Z 128) 12.2e15.2 <0.001*
4.6  0.3 3.9e5.4 <0.001*
90.9  3.2 82.4e98.6 <0.001*
12.9  0.5 11.7e14.8 <0.001*
20.2  1.6 16.0e25.1 <0.001*
77.8  6.2 65.4e90.1 <0.001*
99.0  22.0 (n Z 22) 69.0e149.0 <0.001*
97.0  27.0 (n Z 128) 60.0e204.0 <0.001*
307.9  33.9 228.0e384.0 <0.001*
646.6  211.1 259.0e1000.0 0.003
13.6  5.7 4.1e24.0 0.473
8.1  2.0 4.3e13.4 0.202
d G&K index as well as blood concentrations of Hb, iron, TIBC,
nd 150 healthy controls by Student t test with p < 0.05.
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diagnosed as having Hb, vitamin B12, or folic acid de-
ficiencies by the aforementioned strict World Health Or-
ganization criteria. Thus, IDA patients had a significantly
higher frequency of Hb (p < 0.001) and vitamin B12 de-
ficiencies (pZ 0.002) than healthy controls. In addition, 10
(13.3%) IDA patients and three (2.0%) normal controls had
an abnormally high blood homocysteine level. Thus, there
was also a significant difference in blood homocysteine
level between IDA patients and normal controls
(p Z 0.002).
The oral manifestations in 75 IDA patients and in 150
healthy controls are shown in Table 2. IDA patients had
significantly higher frequencies of all oral manifestations
than healthy controls (p < 0.001 for all), in which burning
sensation of oral mucosa (76.0%), lingual varicosity (56.0%),
dry mouth (49.3%), oral lichen planus (33.3%), and atrophic
glossitis (26.7%) were the five leading oral manifestations
for IDA patients (Table 2).Discussion
This study showed significantly higher frequencies of all
oral manifestations in IDA patients than in healthy controls
(p < 0.001). These oral manifestations included burning
sensation of oral mucosa (76.0%), lingual varicosity (56.0%),
dry mouth (49.3%), OLP (33.3%), AG (26.7%), RAU (25.3%),
numbness of oral mucosa (21.3%), and dysfunction of taste
(12.0%). Our previous studies found burning sensation of
oral mucosa, lingual varicosity, dry mouth, numbness of
oral mucosa, and dysfunction of taste in 100%, 92.5%,
75.7%, 43.9%, and 19.8% of 399 BMS patients, respectively,4
and in 100%, 98.9%, 79.0%, 57.4%, and 27.8% of 176 AG
patients, respectively.6 Because 33.3%, 26.7%, 25.3%, and
18.7% of our 75 IDA patients had concomitant OLP, AG, RAU,
and BMS, respectively, this could explain why our IDA pa-
tients had significantly higher frequencies of all oral man-
ifestations including burning sensation of oral mucosa,
lingual varicosity, dry mouth, numbness of oral mucosa, and
dysfunction of taste than healthy controls. In addition, all
(100%) of our 75 IDA patients had anemia according to the
World Health Organization criteria.2 Anemia patients have
reduced hemoglobin levels and so carry insufficient oxygenTable 2 Oral manifestations in 75 patients with iron deficiency
Oral manifestation Particip
Patients with iron defic
anemia (n Z 75)
Burning sensation 57 (76.0)
Lingual varicosity 42 (56.0)
Dry mouth 37 (49.3)
Oral lichen planus 25 (33.3)
Atrophic glossitis 20 (26.7)
Recurrent aphthous ulcerations 19 (25.3)
Numbness 16 (21.3)
Dysfunction of taste 9 (12.0)
*Comparison of frequency of each oral manifestation between 75 pat
healthy controls by Chi-square test with p < 0.05.to oral mucosa and finally results in atrophy of oral mu-
cosa.1 Iron deficiency may also lead to atrophy of oral
mucosa, because iron is essential to the normal functioning
of oral epithelial cells and in an iron deficiency state oral
epithelial cells turn over more rapidly and produce an
atrophic or immature mucosa.1 Atrophic oral mucosa in IDA
patients could partially explain why a significant number of
our IDA patients had burning sensation and numbness of
oral mucosa and dysfunction of taste. The reasons why BMS
and AG patients may have burning sensation and numbness
of oral mucosa, lingual varicosity, dry mouth, and
dysfunction of taste than healthy controls have been
explained in detail in our previous papers.4,6
This study also found that IDA patients had significantly
lower mean Hb level, RBC count, MCV, Mentzer index, iron
level, and vitamin B12 level as well as significantly higher
mean RDW, G&K index, and TIBC level than healthy con-
trols. IDA patients had severe iron deficiency, which leads
to a significantly reduced production of Hb and RBC, and
also results in the generation of microcytic RBC in IDA
patients.12e18 Moreover, some of our IDA patients also had
vitamin B12 or folic acid deficiency, which is a condition
that can lead to production of macrocytic RBC. Because
small-, normal-, and large-sized RBCs were produced in one
individual in some of our IDA patients, these finally resulted
in an elevated mean RDW in our IDA patients. Although IDA
patients had significant iron deficiency, the bone marrow
hematopoietic function of IDA patients may be nearly
normal; this thus leads to a slightly and significantly lower
mean RBC count in IDA patients.12e18 In addition, a signifi-
cant iron deficiency may result in a significantly elevated
TIBC level in our IDA patients compared to healthy controls.
b-TT and pure IDA patients usually have microcytic and
hypochromic anemia. To date, more than 10 discrimination
indices have been reported using RBC indices obtained by
automated blood count to distinguish b-TT from pure
IDA.12e18 Several authors have calculated the sensitivity
and specificity of these discrimination indices in differen-
tiating b-TT from pure IDA. However, none of these indices
has a sensitivity and specificity of 100% in prediction of b-TT
and pure IDA.12e18 Among these discrimination indices,
most previous investigators agree that the majority of b-TT
patients have Mentzer index < 13 and G&K index < 65,
whereas the majority of pure IDA patients have Mentzeranemia and in 150 age- and sex-matched healthy controls.











ients with iron deficiency anemia and 150 age- and sex-matched
Oral manifestations in IDA patients 87index > 13 and G&K index > 65. These two indices are used
because the Mentzer index was the first proposed index
that is relatively reliable and very easy to calculate (MCV/
RBC)12 and the G&K index has been reported to provide the
highest reliabilities in differentiating b-TT from pure IDA
with the sensitivity of 85.0% and the specificity of 94.8% in
Chinese children18 and the sensitivity of 84.8% and the
specificity of 83.8% in the Palestinian population.16 In our
previous study, all our b-TT patients had Mentzer
index < 13 and G&K index < 65.5 In this study, all healthy
controls and IDA patients except one IDA patient had
Mentzer index > 13 and G&K index > 65. These findings
indicate that both the Mentzer and G&K indices are good
discrimination indices for differentiating b-TT from IDA or
normal status.
Our results show significantly higher frequencies of all
oral manifestations in IDA patients than in healthy controls,
with a burning sensation of oral mucosa, lingual varicosity,
dry mouth, OLP, and AG being the five leading oral mani-
festations for IDA patients. We also found that IDA patients
had significantly lower mean Hb level, RBC count, MCV,
Mentzer index, iron level, and vitamin B12 level as well as
significantly higher mean RDW, G&K index, and TIBC than
healthy controls. We conclude that IDA patients have spe-
cific oral manifestations and a particular blood profile
compared to normal controls.
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